Zymeworks, Inc. (ZYME)
29.69
+0.28
(+0.95%)
USD |
NASDAQ |
Sep 01, 16:00
29.69
0.00 (0.00%)
After-Hours: 20:00
Zymeworks Cash from Operations (TTM) : -119.20M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -119.20M |
| March 31, 2026 | -75.39M |
| December 31, 2025 | -33.07M |
| September 30, 2025 | -62.54M |
| June 30, 2025 | -36.68M |
| March 31, 2025 | -73.45M |
| December 31, 2024 | -107.72M |
| September 30, 2024 | -52.69M |
| June 30, 2024 | -89.55M |
| March 31, 2024 | -71.72M |
| December 31, 2023 | -117.23M |
| September 30, 2023 | 185.38M |
| June 30, 2023 | 158.08M |
| March 31, 2023 | 110.41M |
| December 31, 2022 | 138.19M |
| September 30, 2022 | -230.10M |
| June 30, 2022 | -208.62M |
| March 31, 2022 | -206.01M |
| Date | Value |
|---|---|
| December 31, 2021 | -191.40M |
| September 30, 2021 | -192.26M |
| June 30, 2021 | -162.25M |
| March 31, 2021 | -159.16M |
| December 31, 2020 | -155.85M |
| September 30, 2020 | -141.33M |
| June 30, 2020 | -133.94M |
| March 31, 2020 | -98.46M |
| December 31, 2019 | -82.28M |
| September 30, 2019 | 3.414M |
| June 30, 2019 | 2.199M |
| March 31, 2019 | 20.00M |
| December 31, 2018 | 23.73M |
| September 30, 2018 | 15.23M |
| June 30, 2018 | 13.68M |
| March 31, 2018 | -4.650M |
| December 31, 2017 | 0.2236M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Theravance Biopharma, Inc. | 53.74M |
| BridgeBio Pharma, Inc. | -434.37M |
| Aprea Therapeutics, Inc. | -12.30M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |